Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis | Journal of Neurology, Neurosurgery & Psychiatry
As new migraine prevention treatments are developed, the onset of a preventive effect, how long it is maintained and whether patients initially non-responsive develop clinically meaningful responses with continued treatment can be assessed.. To read the full article, log in using your NHS OpenAthens details.
